North Shore Closes $1.4 Million Non-brokered Private Placement & Enters Into Rio Puerco Option Agreement

North Shore Uranium Ltd. (TSXV:NSU) (‘North Shore‘ or the ‘Company‘) is pleased to announce that it has closed the non-brokered private placement as previously announced on August 7, 2025 (the ‘Offering‘), through the issuance of 24,055,000 non-flow-through units (the ‘NFT Units‘) at a purchase price of $0.05 per NFT Unit and 3,034,922 flow-through units (the…

Read More

NVIDIA Delivers Record Quarter as AI Demand Booms, but China Uncertainty Persists

NVIDIA (NASDAQ:NVDA) delivered another blockbuster quarter, reporting record revenue of US$46.7 billion for its second fiscal period as demand for artificial intelligence (AI) infrastructure continues to surge. The chipmaking giant said sales rose 56 percent from a year earlier and 6 percent from the prior quarter, marking the ninth straight period of year-on-year revenue growth…

Read More

Cobre Limited

Investor Insight Cobre offers investors a rare combination of district-scale copper-silver discovery potential, near-term development upside through its ISCR-ready Ngami copper project, and a capital-light growth model underpinned by major-partner funding and diversified exposure to critical minerals. Overview Cobre (ASX:CBE) is an Australian exploration company unlocking the copper-silver potential of the Kalahari Copper Belt in…

Read More

How to Invest in Gene Stocks and ETFs

Genetics is the study of genes, their variations and hereditary characteristics, as well as how these traits are passed on through generations. So what is genetics investing? When it comes to genetics investing, companies in this niche of the life science sector are mostly focused on four submarkets: DNA sequencing, genetic testing, gene therapy and…

Read More

Can You Invest in Neuralink?

Elon Musk’s Neuralink has captured the public’s attention and imagination with its futuristic vision of connecting the human brain to computers. A July 2024 report by IDTechEx projects that the overall brain computer interface (BCI) market could reach a market value of over US$1.6 billion by 2045. ‘We anticipate that the market for non-invasive solutions…

Read More
Back To Top